Related Experiment Video
Updated: Jan 15, 2026

Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood
Published on: October 12, 2012
Rivaroxaban vs. Enoxaparin for Preventing Venous Thromboembolism and Wound Complications after Knee Surgery: A
Shasha He1,2, Xiangbao Yin3, Yingqi Xu
1Department of Endocrinology and Metabolism, the First Affiliated Hospital of Nanchang University, Nanchang, China.
Abstract:
A systematic review was conducted to compare rivaroxaban with enoxaparin in the prevention of venous thromboembolism (VTE) and wound complications after total knee arthroplasty. Comprehensive searches of electronic databases were conducted, encompassing Medline/PubMed, Embase, and the International Clinical Trials Registry Platform (ICTRP), covering all the available literature up to January 2022. Adhering to the Cochrane methodology for systematic reviews, two independent researchers meticulously screened the retrieved studies, extracted pertinent data, and assessed the quality of the evidence. The review included six studies with 6,627 patients, sourced from Medline/PubMed, Embase, and clinical trial registries. Meta-analysis showed that rivaroxaban significantly reduced symptomatic VTE and deep vein thrombosis (DVT), with relative risks (RR) of 0.55 (p = 0.009) and 0.44 (p = 0.007), respectively. However, there was no significant difference in symptomatic pulmonary embolism (PE), wound complications, major bleeding, or mortality (all p >0.05). Rivaroxaban demonstrated superior efficacy for VTE and DVT prevention without increasing major risks. Key Words: Enoxaparin, Meta-analysis, Rivaroxaban, Wound complications.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Venous Thrombosis IV: Nursing Management
Peripheral Artery Disease V: Postoperative Nursing Management
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Varicose Veins II: Diagnostic Studies and Interprofessional Care

